Phase II trial of radiochemotherapy with daily concomitant and adjuvant intensified (one week on / one week off) temozolomide plus indomethacin in newly diagnosed glioblastoma: UKT-05. - Weiler,M.; Hartmann,C.; Wiewrodt,D. (Int J Rad Biol Phys, 2010)